Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Ascendis Pharma: Yuviwel Approved Despite Legal Challenges (NASDAQ:ASND)
Yuviwel is expected to add only modestly to 2024 revenues, with $30–40 million in 2026 net sales seen as a reasonable target given limited U.S. market penetration. The Yuviwel plus Skytrofa combination, showing much higher efficacy than…
Royalty Pharma (RPRX) Achieves Record Growth and Hits Investment Targets Ahead of Schedule
Royalty Pharma (NASDAQ: RPRX) is one of the dirt cheap stocks to buy now. On February 11, Royalty Pharma reported a year of robust financial performance in 2025, marked by a 16% increase in total portfolio receipts and an 18% jump in Q4 alone. The…
BridgeBio Pharma (BBIO) Achieves Record 2025 Revenue Driven by Attruby Commercial Success
BridgeBio Pharma Inc. (NASDAQ: BBIO) is one of the stocks with explosive growth potential. On February 24, BridgeBio Pharma reported a transformative full-year 2025, marked by a surge in total revenue to $502.1 million. This was driven largely by…
Natco Pharma launches generic of cancer drug in U.S.
Natco Pharma along with its partner Breckenridge Pharmaceutical Inc has launched Pomalidomide Capsules, a generic version of Celgene's Pomalyst in the U.S. market. A thalidomide analogue, the product is indicated for the treatment of multiple…
Natco Pharma launches Pomalidomide capsules in US
Natco Pharma has announced the launch of Pomalidomide Capsules, a generic version of Pomalyst, in the US market. This product, developed in partnership with Breckenridge Pharmaceutical, Inc., is indicated for the treatment of adult patients with…
Citigroup Initiates Coverage on Spyglass Pharma (NASDAQ:SGP)
Investment analysts at Citigroup assumed coverage on shares of Spyglass Pharma (NASDAQ:SGP - Get Free Report) in a report issued on Tuesday, MarketBeat reports. The firm set a 'buy' rating and a $42.00 price target on the stock. Citigroup's price…
Spyglass Pharma (NASDAQ:SGP) Now Covered by Stifel Nicolaus
Investment analysts at Stifel Nicolaus began coverage on shares of Spyglass Pharma (NASDAQ:SGP - Get Free Report) in a note issued to investors on Tuesday, Benzinga reports. The firm set a 'buy' rating and a $42.00 price target on the stock. Stifel…
TD Asset Management Inc Acquires 91,136 Shares of Royalty Pharma PLC $RPRX
TD Asset Management Inc raised its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 88.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 194,202 shares of the…
Rafferty Asset Management LLC Sells 44,792 Shares of BridgeBio Pharma, Inc. $BBIO
Rafferty Asset Management LLC decreased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 22.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The…
Quantbot Technologies LP Makes New $2.82 Million Investment in Royalty Pharma PLC $RPRX
Quantbot Technologies LP bought a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 79,961 shares of the…
Urogen Pharma (NASDAQ:URGN) Shares Gap Up Following Earnings Beat
Urogen Pharma (NASDAQ:URGN - Get Free Report) gapped up before the market opened on Tuesday following a better than expected earnings announcement. The stock had previously closed at $19.02, but opened at $19.54. Urogen Pharma shares last traded at…
Spyglass Pharma (NASDAQ:SGP) Earns Outperform Rating from Analysts at Leerink Partners
Equities researchers at Leerink Partners started coverage on shares of Spyglass Pharma (NASDAQ:SGP - Get Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage set an 'outperform' rating and a $42.00 price…
American Century Companies Inc. Buys 13,797 Shares of Ascendis Pharma A/S $ASND
American Century Companies Inc. lifted its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 2.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional…
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's What Happened
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) shares saw unusually-strong trading volume on Tuesday. Approximately 3,981 shares were traded during mid-day trading, an increase of 30% from the previous…
Mitsubishi UFJ Asset Management Co. Ltd. Buys 44,289 Shares of Royalty Pharma PLC $RPRX
Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 14.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned…
Receive a Daily briefing on Pharma Industry News
Get Started